Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.41
+0.08 (0.80%)
Nov 21, 2024, 11:34 AM EST - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $587.03 million as of November 21, 2024. Its market cap has increased by 54.19% in one year.
Market Cap
587.03M
Enterprise Value
344.94M
1-Year Change
54.19%
Ranking
Category
Stock Price
$9.41
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $587.03M, an increase of 427.00%. That is a compound annual growth rate of 49.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 582.35M | 27.37% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 599.45M |
| OrthoPediatrics | 597.89M |
| Annexon | 596.92M |
| Butterfly Network | 596.27M |
| CureVac | 589.95M |
| Mineralys Therapeutics | 586.03M |
| ABIVAX Société Anonyme | 584.61M |
| Varex Imaging | 576.14M |